About Revenio Group
Revenio Group is a company based in Vantaa (Finland) founded in 2001. The company has 241 employees as of December 31, 2024. Revenio Group has completed 5 acquisitions, including CenterVue, Oscare Medical and Thirona. Revenio Group offers products and services including iCare Tonometry Devices, iCare Eye Fundus Imaging Devices, iCare Perimeters, and iCare Clinical Software.
- Headquarter Vantaa, Finland
- Employees 241 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Revenio Group Oyj
-
Annual Revenue
$107.55 M (USD)7.19as on Dec 31, 2024
-
Net Profit
$19.22 M (USD)-3.2as on Dec 31, 2024
-
EBITDA
$31.05 M (USD)-0.6as on Dec 31, 2024
-
Latest Funding Round
$47.52 M (USD), Post-IPO
Apr 24, 2019
-
Investors
Not available
-
Employee Count
241
as on Dec 31, 2024
-
Investments & Acquisitions
CenterVue
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Revenio Group
Revenio Group is a publicly listed company on the OMXHEX with ticker symbol REG1V in Finland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Revenio Group
Revenio Group offers a comprehensive portfolio of products and services, including iCare Tonometry Devices, iCare Eye Fundus Imaging Devices, iCare Perimeters, and iCare Clinical Software.
Devices for accurate measurement of eye pressure.
Tools for capturing images of the eye fundus.
Devices for visual field testing in eye examinations.
Software for managing and analyzing eye diagnostic data.
People of Revenio Group
Unlock access to complete
Funding Insights of Revenio Group
Investments & Acquisitions by Revenio Group
Revenio Group has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include CenterVue, Oscare Medical and Thirona.
Investment portfolio details for Revenio Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A platform for secure clinical data sharing is offered by iCare OCULO.
|
Locked | Locked | 2015 | Locked | |
|
AI-based medical image analysis software is provided for diagnostics.
|
Locked | Locked | 2014 | Locked | |
|
Fundus imaging devices are developed for ophthalmological diagnostics.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Revenio Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Revenio Group
Detailed financials for Revenio Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Revenio Group Comparisons
Peer comparison for Revenio Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Revenio Group
Detailed competitors of Revenio Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Revenio Group
Complete news archive for Revenio Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Revenio Group
Revenio Group was founded in 2001 and raised its 1st funding round 18 years after it was founded.
Revenio Group is headquartered in Vantaa, Finland.
As of Dec 31, 2024, the latest employee count at Revenio Group is 241.
Annual revenue of Revenio Group is $107.55M as on Dec 31, 2024.
Revenio Group was founded in 2001 and is based in Vantaa, Finland. Operations focus on the medical diagnostics sector, where handheld devices are developed and commercialized. Subsidiaries include Oscare Medical, which produces ultrasound tools for osteoporosis and osteopenia detection, and Icare Finland, which manufactures tonometers for intraocular pressure measurement at point-of-care. A dedicated research unit is advancing a device for skin cancer identification.
Revenio Group offers iCare Tonometry Devices, iCare Eye Fundus Imaging Devices, iCare Perimeters, and iCare Clinical Software.
Yes, Revenio Group is publicly traded on OMXHEX under the ticker symbol REG1V.
Revenio Group has made 5 acquisitions, including CenterVue, Oscare Medical, and Thirona.
The ticker symbol of Revenio Group is REG1V on OMXHEX.